XML 31 R7.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Changes in Equity - CAD ($)
$ in Thousands
Total
Share capital
Contributed surplus
Retained earnings
Currency translation adjustments
Cash flow hedge reserve
Total accumulated other comprehensive income
Non-controlling interests
Beginning balance at Mar. 31, 2023 $ 1,130,583 $ 520,633 $ 15,468 $ 530,707 $ 51,206 $ 8,834 $ 60,040 $ 3,735
Changes in equity [abstract]                
Net income (loss) 194,181     193,735       446
Other comprehensive income (loss) 3,475     (406) (2,571) 6,686 4,115 (234)
Comprehensive income 197,656     193,329 (2,571) 6,686 4,115 212
Non-controlling interest (195)     471       (666)
Stock-based compensation 11,253   11,253          
Exercise of stock options 2,152 2,754 (602)          
U.S. initial public offering (note 17) 366,332 366,332            
U.S. initial public offering (23,820) (23,820)            
Common shares held in trust (14) (2)   (12)        
Ending balance at Mar. 31, 2024 1,683,947 865,897 26,119 724,495 48,635 15,520 64,155 3,281
Changes in equity [abstract]                
Net income (loss) (27,978)     (28,049)       71
Other comprehensive income (loss) 102,902     (120) 122,292 (19,592) 102,700 322
Comprehensive income 74,924     (28,169) 122,292 (19,592) 102,700 393
Non-controlling interest 0     94       (94)
Stock-based compensation 10,564   10,564          
Exercise of stock options 495 639 (144)          
U.S. initial public offering (14,690) (14,690)            
Common shares held in trust (45,883) (9,831)   (36,052)        
Ending balance at Mar. 31, 2025 $ 1,709,357 $ 842,015 $ 36,539 $ 660,368 $ 170,927 $ (4,072) $ 166,855 $ 3,580